Cargando…
External verification and improvement of the Neo-Bioscore staging system in a Chinese cohort
BACKGROUND: Accurately predicting outcomes for patients with breast cancer receiving neoadjuvant chemotherapy (NAC) is critical for clinical decisions. Prognostic models applicable to the Chinese population remain limited. The Neo-Bioscore staging system has been utilized as a predictive model for s...
Autores principales: | Geng, Rui, Min, Ningning, Zheng, Yiqiong, Hong, Chenyan, Wu, Rilige, Wu, Huan, Wei, Yufan, Zhang, Yanjun, Li, Xiru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263773/ https://www.ncbi.nlm.nih.gov/pubmed/35813331 http://dx.doi.org/10.21037/atm-21-6738 |
Ejemplares similares
-
Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study
por: Xu, Ling, et al.
Publicado: (2021) -
Validation of CPS+EG, Neo‐Bioscore, and modified Neo‐Bioscore staging systems after preoperative systemic therapy of breast cancer: Protocol of a retrospective multicenter cohort study in China
por: Xu, Ling, et al.
Publicado: (2018) -
Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data
por: Hong, Chenyan, et al.
Publicado: (2022) -
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore
por: Laas, Enora, et al.
Publicado: (2021) -
Evaluation of the relationship between Ki67 expression level and neoadjuvant treatment response and prognosis in breast cancer based on the Neo-Bioscore staging system
por: Sullu, Yurdanur, et al.
Publicado: (2023)